Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Sensors (Basel, Switzerland)|November 9, 2024
Smart Compression Sock for Early Detection of Diabetic Foot UlcersJulia Billings, Julia Gee, Zinah Ghulam, et al.
International Journal of Cancer|September 10, 2009
The effects of gefitinib in tamoxifen-resistant and hormone-insensitive breast cancer: a phase II studyEleanor Gutteridge, Amit Agrawal, Robert Nicholson, et al.
RSC Medicinal Chemistry|February 27, 2023
Pyridine based dual binding site aromatase (CYP19A1) inhibitorsAhmed G Eissa, Lauren E Powell, Julia Gee, et al.
Breast Cancer Research and Treatment|December 8, 2005
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cellsStephen Hiscox, Liam Morgan, Tim P Green, et al.
European Journal of Medicinal Chemistry|July 14, 2022
4th generation nonsteroidal aromatase inhibitors: An iterative SAR-guided design, synthesis, and biological evaluation towards picomolar dual binding inhibitorsAhmed G Eissa, Denise Barrow, Julia Gee, et al.
Breast Cancer Research : BCR|December 6, 2008
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cellsAnnabel C Borley, Stephen Hiscox, Julia Gee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2006
Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cellsFrancesca Greco, María J Vicent, Siobhan Gee, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Oxidative Stress-Responsive 1 Kinase Catalytic Activity Promotes Triple Negative Breast Cancer Oncogenic PotentialAzeza M Fdel, Loren Waters, Ira Sharma, et al.
Frontiers in Oncology|July 6, 2016
Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine ResistanceRebecca Bellerby, Chris Smith, Sue Kyme, et al.
Breast Cancer Research and Treatment|March 17, 2009
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistanceNicholas B P Thomas, Iain R Hutcheson, Lee Campbell, et al.
Pageof 3